DOP2016000198A - Formulaciones tópicas de heparina - Google Patents
Formulaciones tópicas de heparinaInfo
- Publication number
- DOP2016000198A DOP2016000198A DO2016000198A DO2016000198A DOP2016000198A DO P2016000198 A DOP2016000198 A DO P2016000198A DO 2016000198 A DO2016000198 A DO 2016000198A DO 2016000198 A DO2016000198 A DO 2016000198A DO P2016000198 A DOP2016000198 A DO P2016000198A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- topical formulations
- present
- heparine
- formulations
- topical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con formulaciones tópicas avanzadas de sales farmacéuticamente aceptables de Heparina que proporcionan penetración transdérmica mejorada. La presente invención proporciona formulaciones líquidas, no pegajosas, claras en las que el fármaco está listo para absorción y que son adecuadas para administración en la forma de una solución o una pulverización. Las formulaciones tópicas de la presente invención no forman película con escamas o similar a gel sobre la superficie de la piel luego de aplicación tópica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN475MU2014 | 2014-02-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2016000198A true DOP2016000198A (es) | 2016-10-31 |
Family
ID=52684592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2016000198A DOP2016000198A (es) | 2014-02-10 | 2016-08-03 | Formulaciones tópicas de heparina |
Country Status (25)
Country | Link |
---|---|
US (1) | US9861655B2 (es) |
EP (1) | EP3104839B1 (es) |
JP (1) | JP6275877B2 (es) |
KR (1) | KR101822133B1 (es) |
CN (1) | CN106163498A (es) |
AP (1) | AP2016009350A0 (es) |
AR (1) | AR099333A1 (es) |
AU (1) | AU2015213569B2 (es) |
CA (1) | CA2938388C (es) |
CL (1) | CL2016001952A1 (es) |
CU (1) | CU24444B1 (es) |
DK (1) | DK3104839T3 (es) |
DO (1) | DOP2016000198A (es) |
EA (1) | EA032200B1 (es) |
EC (1) | ECSP16069947A (es) |
IL (1) | IL246974B (es) |
MA (1) | MA39304B1 (es) |
MX (1) | MX357765B (es) |
MY (1) | MY182620A (es) |
NZ (1) | NZ722830A (es) |
PE (1) | PE20161173A1 (es) |
PH (1) | PH12016501500B1 (es) |
TW (1) | TWI538697B (es) |
UA (1) | UA118279C2 (es) |
WO (1) | WO2015118512A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5927506B2 (ja) * | 2010-04-13 | 2016-06-01 | レルマダ セラピューティクス、インク. | 1−メチル−2’,6’−ピペコロキシリダイドの皮膚医薬組成物および使用方法 |
CN112546061B (zh) * | 2021-02-25 | 2021-06-11 | 中南大学湘雅医院 | 一种肝素类药物组合物、喷鼻剂及其制备方法及应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3323389A1 (de) * | 1983-06-29 | 1985-01-10 | B. Braun Melsungen Ag, 3508 Melsungen | Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden |
JPH02207018A (ja) * | 1989-02-07 | 1990-08-16 | Kao Corp | 皮膚外用剤 |
CA2201358C (en) | 1994-09-30 | 2004-06-08 | Jurgen Regenold | Pharmaceutical composition |
IT1275955B1 (it) | 1995-03-22 | 1997-10-24 | Dompe Spa | Formulazioni farmaceutiche in forma di gel tissotropico |
JPH10279466A (ja) * | 1997-04-07 | 1998-10-20 | Kose Corp | 外用剤 |
US6761903B2 (en) | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
BRPI0101486B1 (pt) | 2001-04-17 | 2017-09-19 | Cristália Produtos Químicos Farmacêuticos Ltda. | Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns |
NZ577604A (en) * | 2006-11-15 | 2012-06-29 | Arthritis Relief Plus Ltd | Topical formulation and uses thereof |
IT1400232B1 (it) * | 2010-05-07 | 2013-05-24 | Advance Holdings Ltd | Composizione farmaceutica topica comprendente eparina |
AU2012236493A1 (en) * | 2011-04-01 | 2013-10-31 | University Of Florida Research Foundation, Inc. | Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics |
-
2015
- 2015-02-10 CA CA2938388A patent/CA2938388C/en active Active
- 2015-02-10 DK DK15710252.6T patent/DK3104839T3/da active
- 2015-02-10 KR KR1020167023895A patent/KR101822133B1/ko active IP Right Grant
- 2015-02-10 EA EA201691596A patent/EA032200B1/ru unknown
- 2015-02-10 AU AU2015213569A patent/AU2015213569B2/en active Active
- 2015-02-10 MY MYPI2016702732A patent/MY182620A/en unknown
- 2015-02-10 AP AP2016009350A patent/AP2016009350A0/en unknown
- 2015-02-10 NZ NZ722830A patent/NZ722830A/en unknown
- 2015-02-10 MX MX2016010399A patent/MX357765B/es active IP Right Grant
- 2015-02-10 JP JP2016568157A patent/JP6275877B2/ja active Active
- 2015-02-10 AR ARP150100384A patent/AR099333A1/es unknown
- 2015-02-10 MA MA39304A patent/MA39304B1/fr unknown
- 2015-02-10 TW TW104104460A patent/TWI538697B/zh not_active IP Right Cessation
- 2015-02-10 CN CN201580007796.6A patent/CN106163498A/zh active Pending
- 2015-02-10 PE PE2016001445A patent/PE20161173A1/es unknown
- 2015-02-10 EP EP15710252.6A patent/EP3104839B1/en active Active
- 2015-02-10 US US15/116,060 patent/US9861655B2/en not_active Expired - Fee Related
- 2015-02-10 WO PCT/IB2015/050986 patent/WO2015118512A1/en active Application Filing
- 2015-02-10 UA UAA201608842A patent/UA118279C2/uk unknown
- 2015-02-10 CU CU2016000119A patent/CU24444B1/es unknown
-
2016
- 2016-07-27 IL IL246974A patent/IL246974B/en active IP Right Grant
- 2016-07-28 PH PH12016501500A patent/PH12016501500B1/en unknown
- 2016-08-02 CL CL2016001952A patent/CL2016001952A1/es unknown
- 2016-08-03 DO DO2016000198A patent/DOP2016000198A/es unknown
- 2016-08-26 EC ECIEPI201669947A patent/ECSP16069947A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
CL2018003681A1 (es) | Derivados de ácido borónico y usos terapéuticos de los mismos | |
CL2018003597A1 (es) | Pirimidin-2-ilamino-1h-pirazoles como inhibidores delrrk2 para el uso en el tratamiento de trastornos neurodegenerativos. | |
ES2973279T3 (es) | Usos de medicamento de duloxetina·HCl en la preparación de una composición farmacéutica para el tratamiento de cáncer | |
DK3273942T3 (da) | Mikronåleplaster til indgivelse af en aktiv bestanddel til huden | |
BR112016028961A8 (pt) | fibras eletrotorcidas, seu método de preparação e seu uso, bem como composição, e kit | |
CL2015003690A1 (es) | Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington. | |
CL2015002733A1 (es) | Composición farmacéutica de clorhidrato de s-cetamina. | |
BR112017007123A2 (pt) | derivados de tetrahidroisoquinolina | |
IL260462B1 (en) | Gel preparations for administering a drug through the skin to maximize drug concentrations in the rough layer and serum and methods of using them | |
CR20150360A (es) | Sistema de liberación transdérmica | |
BR112016000350A8 (pt) | métodos de tratamento de lesões inflamatórias da rosácea e usos de uma composição farmacêutica | |
AR096402A1 (es) | Medicamento de metformina y dihidroquercetina | |
CY1124294T1 (el) | Τοπικο σκευασμα | |
ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
CO2018007535A2 (es) | Análogos de cortistatina y usos de los mismos | |
BR112017013273A2 (pt) | emplastro em gel | |
DOP2016000198A (es) | Formulaciones tópicas de heparina | |
CL2017001773A1 (es) | Análogos de calcitonina para tratar enfermedades y trastornos. | |
ECSP16086232A (es) | (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
CL2016000397A1 (es) | Tratamiento contra el cáncer | |
CL2016000543A1 (es) | Uso de pidotimod o sus estereoisómeros y/o sales fisiológicamente aceptables para preparar un medicamento útil en el tratamiento de enfermedades asociadas con la inflamación, donde hay una hiperactivación aberrante de la vía no canónica de nfkb. | |
CR20140526A (es) | Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis | |
AR103188A1 (es) | Formulaciones de paracetamol inyectables |